Beth Seidenberg, the founding managing director of Westlake Village BioPartners, was selected as the 2022 Woman of the Year by the Healthcare Businesswomen’s Association.
Seidenberg is a longtime life sciences expert who has invested in and incubated more than 20 biotech ventures since 2005. She has held leadership roles at Amgen, where she was a chief medical officer and head of global development, and at Bristol Myers Squibb and Merck Research Laboratories.
Seidenberg sees the current era as the golden age of biotech.
“The pace and quality of innovation has hit an inflection point,” Seidenberg said in a statement. “With Westlake Village BioPartners, we have the freedom and expertise to turn the next big technologies into products and companies that benefit human health.”
Westlake Village BioPartners has played leading roles in financing for Woodland Hills-based biopharma company Acelyrin and Thousand Oaks-based Capsida Biotherapeutics.
Seidenberg along with other honorees “exemplify the personas of a new era of leadership,” the association said in a statement.
A celebration for the honorees will be held in person in New York City on May 10 and will be broadcast virtually.
